HMGB3P14: A Drug Target / Disease Biomarker (G100873899)

Target Name: HMGB3P14

NCBI ID: G100873899

HMGB3P14

Other Name(s): high mobility group box 3 pseudogene 14 | High mobility group box 3 pseudogene 14

HMGB3P14: A Drug Target / Disease Biomarker

HMGB3P14 is a protein that is expressed in various tissues throughout the body. It is a key player in the homeostasis of cells, and has been identified as a potential drug target or biomarker.

HMGB3P14 is a member of the heparan sulfate proteoglycan (HSPG) family, which is a large superfamily of proteins that are involved in the extracellular matrix (ECM) of cells. HSPG proteins are known for their ability to interact with a wide range of molecules, including drugs, toxins, and signaling proteins. This makes them a promising target for the development of new therapeutic agents.

One of the key reasons why HMGB3P14 is considered a potential drug target is its role in the regulation of cellular processes that are important for the survival and growth of cells. For example, HMGB3P14 has been shown to play a role in the regulation of cell adhesion, a process that is critical for the formation and maintenance of tissues and organs.

In addition to its role in cell adhesion, HMGB3P14 has also been shown to be involved in the regulation of cellular signaling pathways that are important for the growth and differentiation of cells. For example, studies have shown that HMGB3P14 can interact with the protein Stat3, which is involved in the regulation of cell growth and differentiation. This interaction between HMGB3P14 and Stat3 suggests that HMGB3P14 may be a useful target for the development of drugs that can inhibit the activity of Stat3.

Another potential reason why HMGB3P14 is considered a potential drug target is its role in the regulation of inflammation. HMGB3P14 has been shown to play a role in the regulation of the immune response, and has been shown to interact with the protein PD-L1. This suggests that HMGB3P14 may be a useful target for the development of drugs that can inhibit the activity of PD-L1, which is involved in the regulation of immune responses.

In addition to its potential role in the regulation of cell signaling pathways and inflammation, HMGB3P14 has also been shown to play a role in the regulation of the extracellular matrix. For example, studies have shown that HMGB3P14 can interact with the protein FN1, which is involved in the regulation of cell adhesion and the formation of tissues and organs. This suggests that HMGB3P14 may be a useful target for the development of drugs that can inhibit the activity of FN1.

Overall, HMGB3P14 is a protein that has been identified as a potential drug target or biomarker due to its role in the regulation of cellular processes that are important for the survival and growth of cells. Further research is needed to determine the full extent of its potential as a drug target or biomarker.

Protein Name: High Mobility Group Box 3 Pseudogene 14

The "HMGB3P14 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HMGB3P14 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets